Boston, MA – According to filings with the U.S. Securities and Exchange Commission, Akili Interactive Labs is raising $151,683,372.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Eddie Martucci played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Akili Interactive Labs
At Akili, we believe there is potential for medicine to be developed, delivered and experienced in a completely different way. We’re bringing together world-class neuroscience with exceptional creativity and video game development to challenge the status quo of medicine. Our digital medicine is not delivered through a pill, but rather through a patented and captivating video game experience. Effective medicine that’s captivating and enjoyable to use now that’s refreshing! We’re continuously evaluating new technologies and are advancing a broad pipeline of programs to treat cognitive deficiency and improve symptoms associated with medical conditions across neurology and psychiatry, including attention-deficit hyperactivity/ disorder (ADHD), major depressive disorder (MDD), autism spectrum disorder (ASD) and various inflammatory diseases.

To learn more about Akili Interactive Labs, visit http://www.akiliinteractive.com/

Contact:
Eddie Martucci, Chief Executive Officer
617-456-0597
martucci@akiliinteractive.com
https://www.linkedin.com/in/eddiemartucci/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved